Singapore at a glance
- Population
- 6.1 million 2025
- Life expectancy at birth
- 83.3 years, 2024
- People aged 65 and over
- 14.2 % of people, 2025
- Health spending per person
- 3,922 US$ per person, 2023
- Doctors
- 2.83 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
Singapore Ophthalmic Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Disease, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$36.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $46.3 Mn | — | — |
| 2025 (base) | $49.3 Mn | +$2.9 Mn | — |
| 2026 (forecast) | $52.4 Mn | +$3.1 Mn | +6.3% |
| 2027 (forecast) | $55.7 Mn | +$3.3 Mn | +13% |
| 2028 (forecast) | $59.2 Mn | +$3.5 Mn | +20.1% |
| 2029 (forecast) | $62.9 Mn | +$3.7 Mn | +27.7% |
| 2030 (forecast) | $66.9 Mn | +$4.0 Mn | +35.7% |
| 2031 (forecast) | $71.1 Mn | +$4.2 Mn | +44.3% |
| 2032 (forecast) | $75.6 Mn | +$4.5 Mn | +53.4% |
| 2033 (forecast) | $80.3 Mn | +$4.8 Mn | +63% |
| 2034 (forecast) | $85.4 Mn | +$5.1 Mn | +73.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $49.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $85.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, disease and end user (see all) |
| Key players | Alcon, Johnson & Johnson, Bausch and Lomb, Carl Zeiss Meditec, The Cooper Companies Inc. and 1 more (see all) |
| Regulator in Singapore | HSASource: Health Sciences Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Ophthalmic devices diagnose and treat eye disease and vision problems, from eye scanners to surgical lasers and lenses.
Key segments of the ophthalmic devices market include product (Surgical Devices, Diagnostic and Monitoring Devices and Vision Correction) and disease (Cataract, Glaucoma and Retinal Disorders).
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the ophthalmic devices market.
Smart implants, less invasive techniques and growing access to surgery in emerging economies give the ophthalmic devices market room to grow.
Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the ophthalmic devices market.
The ophthalmic devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices.[1] MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.[2]
[1] Health Sciences Authority. Checked 14 Nov 2026.
[2] CPF Board, MediShield Life. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how ophthalmic devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Singapore.
What doctors and scientists are doing in Ophthalmic Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.
From our blog
Singapore
Singapore
Singapore
Singapore
Singapore
Singapore
Digital Health · Singapore
Digital Health · Singapore
Healthcare Services · Singapore
Healthcare Services · Singapore
Pharmaceuticals · Singapore
Healthcare Services · Singapore